Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
The current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for ear...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Urology Research Center
2020-08-01
|
| Series: | Translational Research in Urology |
| Subjects: | |
| Online Access: | https://www.transresurology.com/article_120191.html |